Abstract
Complications, acute and chronic, patients with diabetes mellitus type 1 (DM1) are the reflection of variability in glycemic control caused by loss of blood glucose levels in consequence of the absence or insufficiency in insulin production by pancreatic beta cells. Thus, insulin therapy in these patients is fully able to delay disease progression macro and microvascular changes, however,…